1. bookVolumen 71 (2021): Edición 1 (March 2021)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

A cost-effective and sensitive TLC-densitometric identification of meloxicam

Publicado en línea: 20 Jul 2020
Volumen & Edición: Volumen 71 (2021) - Edición 1 (March 2021)
Páginas: 143 - 152
Aceptado: 24 Mar 2020
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. A. Walsem, R. Nixon, P. Guyot, A. Karabis and A. R. Moore, Relative benefit-risk comparing diclofe nac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis, Arthritis Res. Ther.19 (2015) 66–72; https://doi.org/10.1186/s13075-015-0554-010.1186/s13075-015-0554-0441179325879879Search in Google Scholar

2. A. Pyka, Detection progress of selected drugs in TLC, Biomed. Res. Int.2014 (2014) Article ID 732078 (19 pages); https://doi.org/10.1155/2014/73207810.1155/2014/732078391429624551853Search in Google Scholar

3. M. Dołowy and A. Pyka-Pająk, Development of new procedures for the detection and separation of salicylic acid and acetylsalicylic acid using thin-layer chromatography with densitometry, J. Planar Chromatogr. – Modern TLC30 (2017) 363–374; https://doi.org/10.1556/1006.2017.30.5.510.1556/1006.2017.30.5.5Search in Google Scholar

4. W. Parys, K. Bober, A. Pyka-Pająk and M. Dołowy, The application of TLC and densitometry for quantitative determination of meloxicam in tablets, Curr. Pharm. Anal.15 (2019) 785–794; https://doi.org/10.2174/157341291566619021215574010.2174/1573412915666190212155740Search in Google Scholar

5. M. Starek and J. Krzek, TLC determination of meloxicam in tablets and after acidic and alkaline hydrolysis, Acta Pol. Pharm. Drug Res.69 (2012) 225–235.Search in Google Scholar

6. N. Desai and P. Amin, Stability indicating HPTLC determination of meloxicam, Indian J. Pharm. Sci.70 (2008) 644–647; https://doi.org/10.4103/0250-474X.4540610.4103/0250-474X.45406303829221394264Search in Google Scholar

7. M. Starek, Separation and determination of four oxicams in pharmaceutical formulations by thin-layer chromatographic-densitometric method, J. Planar Chromatogr. – Modern TLC24 (2011) 367–372; https://doi.org/10.1556/JPC.24.2011.5.110.1556/JPC.24.2011.5.1Search in Google Scholar

8. H. Hopkała and A. Pomykalski, TLC analysis of inhibitors of cyclooxygenase and videodensitometric determination of meloxicam and tiaprofenic acid, J. Planar Chromatogr. – Modern TLC16 (2003) 107–111; https://doi.org/10.1556/JPC.16.2003.2.410.1556/JPC.16.2003.2.4Search in Google Scholar

9. J. Shaji and D. Varkey, Development of a validated stability-indicating HPTLC method for determination of meloxicam in bulk and pharmaceutical formulations: Pertinence to ICH guidelines, Int. J. Pharm. Pharm. Sci.4 (2012) 160–169.Search in Google Scholar

10. B. Mamatha, G. Ushasree and V. U. Maheswara Rao, Analytical techniques for estimation of meloxicam in bulk and pharmaceutical dosage forms: A review, Int. J. Pharm. Res. Anal.5 (2015) 74–77.Search in Google Scholar

11. A. Noreen, S. Ahmed, Z. Anwar and I. Ahmad, Analytical techniques for determination of meloxicam in pharmaceutical formulations and biological samples, Baqai J. Health Sci.19 (2016) 59–74.Search in Google Scholar

12. International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH, Geneva 2005; http://www.ich.org; last access date March 15, 2019.Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo